Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Canton Biologics logo — Reliable, efficient, and innovative, global biologics CDMSO...

Canton Biologics

Reliable, efficient, and innovative, global biologics CDMSO for Biotech.

Founded 2016 China Guangzhou, China 31 employees Series C Total: $303.00M Biotechnology, Manufacturing

General Information

Company Name Canton Biologics
Founded Year 2016
Location China Guangzhou, China
Founders / Decision Makers
Team member
Employees 31
Industries Biotechnology, Manufacturing
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Canton Biologics. To contact Canton Biologics, visit cantonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Canton Biologics compare?

A PDF of Canton Biologics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Canton Biologics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Canton Biologics

Canton Biologics is a biotechnology company specializing in providing bio-pharmaceutical development, manufacturing, and supply chain services for global pharmaceutical enterprises. Established in 2016 and headquartered in China, the company has made significant strides in the biologics industry. It boasts a team of over 300 scientists with extensive experience and a high level of expertise, with over 60% holding advanced degrees. The company's last investment, a CNY300.00M Series C investment, took place on 13th September 2023 and was led by prominent investors including SDIC Ventures, Taipu Life Sciences Investment, Guangdong Technology Financial Group, and Qianyin Investment. This funding signifies strong support and confidence in the company's potential and progress. Canton Biologics' offerings include a wide range of services such as Biologics CDMO covering Monoclonal Antibody, Bispecific Antibody, Fusion Protein, Recombinant Protein, and Vaccine, as well as Cell and Gene Therapy (CGT) CDMO, and Global Clinical Supply with capabilities in manufacturing, packaging, storage, and distribution. The company has also made remarkable advancements in operational efficiency, setting a new industry record by completing the process from DNA to CMC in just 7 months. Additionally, Canton Biologics boasts 13+5 manufacturing lines that comply with China, US, and EU GMP standards, further solidifying its position as a reliable and innovative partner for pharmaceutical development. In conclusion, Canton Biologics' strong foundation, impressive service offerings, and recent substantial investment point to its potential to become the preferred global Biologics CDMO for Biotech, making it a compelling prospect for venture capital firms seeking opportunities in the biotechnology and manufacturing sectors.

Business keywords: biologics, CRDMSO, Contract Development Manufacture Organization, CMC platform, Antibody Optimization, Cell Line Development, Process Development, Biochemical Characterization, Clinical Bioanalysis, commercial manufacturing, Biopharmaceuticals, CDMO, Cell and Gene Therapy, Global Biotech, Regulatory Standards

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY300.00M 5
SDIC Ventures Rongtuo Capital Management
SDIC Ventures, Rongtuo Capital Management +3
13 Sep 2023
Angel Round CNY3.00M 1
Gortune Investment
Gortune Investment
04 Jul 2018

Canton Biologics Alternatives & Competitors

View All Alternatives
Canton Biologics vs
CMAB Biopharma
CMAB Biopharma China

Exclusively focused on delivering fully integrated CDMO services for biologics

Series B
38 employees
Biopharma, Biotechnology
Compare Canton Biologics vs CMAB Biopharma
Canton Biologics vs
Cytovance Biologics
Cytovance Biologics United States

We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner.

Debt Financing
206 employees
Biotechnology, Manufacturing
Compare Canton Biologics vs Cytovance Biologics
Canton Biologics vs
JOINN Biologics US Inc.
JOINN Biologics US Inc. United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Compare Canton Biologics vs JOINN Biologics US Inc.
View all alternatives

FAQ About Canton Biologics

Reliable, efficient, and innovative, global biologics CDMSO for Biotech.
Canton Biologics was founded in 2016.
Canton Biologics is headquartered in Guangzhou, China.
Canton Biologics operates in Biotechnology and Manufacturing. Its work centres on biologics, CRDMSO, Contract Development Manufacture Organization and CMC platform.
Canton Biologics has approximately 31 employees.
Canton Biologics has completed 2 funding rounds, raising a total of $303.00M. The latest funding stage is Series C.
Top alternatives and competitors to Canton Biologics include CMAB Biopharma, Cytovance Biologics, JOINN Biologics US Inc., Cognate BioServices, a Charles River Company, Samsung Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Canton Biologics and CMAB Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Canton Biologics, https://bouncewatch.com/company/canton-biologics, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes